Procter & Gamble (PG) Q1 2026 earnings review
Beauty Shines, But Core Segments Stall and Margins Squeeze; Guidance Held Despite Cost Relief
Procter & Gamble started its fiscal year with steady but uninspiring results. Q1 organic sales grew 2% and Core EPS grew 3%, landing squarely within its long-term algorithm. The Beauty segment was a standout performer, accelerating to 6% growth, largely fueled by a recovery in China. However, this strength was offset by stagnation in the company's largest segments, Fabric & Home Care and Baby Care, which both posted 0% growth amid heightened competition. Profitability remains a key concern, with core gross margin contracting by 50 bps. Tellingly, P&G maintained its cautious FY26 guidance (0-4% organic growth, 0-4% core EPS growth) despite a significant reduction in expected tariff and commodity costs, signaling that this cost relief will be reinvested to defend market share rather than boost near-term earnings.
🐂 Bull Case
The Beauty segment grew 6% organically, a significant step-up from prior quarters. This was driven by a rebound in China, where premium innovations on brands like Olay and Safeguard are gaining traction.
The company delivered strong operating cash flow of $5.4 billion and an adjusted free cash flow productivity of 102%. This financial strength allows for continued shareholder returns, with $3.8 billion returned in Q1 alone.
🐻 Bear Case
The company's two largest segments, Fabric & Home Care and Baby Care, which represent over half of total sales, both recorded 0% organic growth, indicating significant competitive pressure.
Core gross margin contracted for the fourth consecutive quarter. Despite significant productivity savings, the company is struggling to offset unfavorable mix, reinvestments, and input costs.
Management maintained its full-year EPS guidance despite a ~$500M reduction in expected cost headwinds. This implies weaker underlying operational performance, with the cost relief being used to fund investments to defend market share.
⚖️ Verdict: ⚪
Mixed. While the acceleration in Beauty and the recovery in China are positive signs, they are overshadowed by weakness in core franchises and ongoing margin erosion. The decision to reinvest cost savings rather than raise guidance highlights the defensive position P&G is in, prioritizing market share stability over near-term profit growth. The results are steady but lack a clear catalyst for upside.
Key Themes
Gross Margin Compression Continues
Core gross margin fell 50 basis points YoY, marking the fourth straight quarter of contraction. According to the company, benefits from 140 bps of productivity savings were more than offset by 100 bps of unfavorable mix, 70 bps of product reinvestments, and another 70 bps from higher tariffs and commodities. This indicates that even with aggressive cost-cutting, P&G is unable to fully protect profitability amid cost pressures and a shift in its product mix.
Stagnation in Core Franchises
The company's growth engines have stalled. Fabric & Home Care and Baby, Feminine & Family Care, which together account for 58% of total revenue, both posted 0% organic sales growth. Management acknowledged heightened competitive promotional activity in the U.S. and Europe for these categories. This weakness in its largest, most critical segments is the primary reason for the company's muted overall growth rate.
Beauty Segment Re-Accelerates, Fueled by China
The Beauty segment was the key bright spot, with organic sales growth accelerating to 6%, its best performance in over a year. Skin & Personal Care grew high single digits. This rebound was heavily supported by a 5% organic sales growth in Greater China, where premium innovations on Olay and Safeguard drove 9% growth in Personal Care and the SK-II brand grew double-digits. This marks a positive turn for a segment that has previously been a drag on results.
Market Share Losses Point to Competitive Gaps
A specific data point contradicting the 'strong execution' narrative is the 30 basis point decline in global aggregate market share. Furthermore, only 24 of the company's top 50 category/country combinations held or grew share this quarter, down from 28 a year ago. Management cited increased competitor aggressiveness as the cause, effectively admitting that its current offerings are losing ground in key battles.
Productivity & Restructuring to Fund the Fight
P&G's productivity program continues to be a crucial financial lever, delivering 230 basis points of benefit in the quarter. Management also confirmed its major restructuring program, which includes reducing up to 7,000 non-manufacturing roles, is on track. These savings are the fuel that allows P&G to increase investments in innovation and marketing to combat the competitive pressures without completely sacrificing the bottom line.
Innovation Pipeline Focused on Core Segments
Management is deploying its primary strategic weapon—innovation—to address the weakness in its core segments. Key initiatives discussed include the 'biggest upgrade to Tide liquid detergent in 20 years', the national online launch of the new 'Tide evo' fiber-based detergent, and a multi-phase restage of the mid-tier Pampers Baby Dry line. The success of these launches will be critical for reigniting growth in the second half of the year.
Other KPIs
The company demonstrated strong cash generation in the first quarter. Operating Cash Flow was $5.4 billion, and Adjusted Free Cash Flow Productivity was an impressive 102%. This provides significant financial flexibility to fund the company's large dividend, share repurchases, and increased investments in the business.
P&G returned $3.8 billion to shareholders in the quarter, consisting of $2.55 billion in dividends and $1.25 billion in share repurchases. The company remains on track to deliver its full-year plan to return approximately $15 billion to shareholders.
After being a significant drag on performance, the Greater China region returned to growth with a 5% increase in organic sales. This marks a positive sequential improvement and was driven by strong innovation and execution, with Pampers and SK-II each growing double-digits in the market.
Guidance
Decelerating. The company maintained its guidance for Core EPS growth of 0% to +4%. The midpoint of +2% represents a continued deceleration from 3.6% growth in FY25 and 11.7% in FY24, reflecting the ongoing challenging operating environment.
Stable. The full-year guidance was maintained at 0% to +4%, with a midpoint of 2%. This implies no significant acceleration from the 2% growth delivered in Q1 and the 2% growth for the full prior fiscal year.
The company's outlook for tariff and commodity headwinds improved by a combined ~$500 million after-tax ($0.20 per share) versus the prior quarter's forecast. However, management did not raise EPS guidance, stating they will reinvest these savings to support innovation and competitiveness. This is a clear signal that defending market share is the top priority over delivering near-term earnings upside.
Management explicitly guided for Q2 to be the 'softest growth quarter for the year' due to lapping tough comparisons related to retailer orders around port strikes in the prior year. Growth is expected to be stronger in the second half of the fiscal year.